SG Americas Securities
HURA

SG Americas Securities’s TuHURA Biosciences HURA Stock Holding History

SG Americas Securities’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,608
Closed -$41K – 3819
2025
Q3 		$41K Buy
+16,608
New +$43.7K ﹤0.01% 3221

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

SG Americas Securities's HURA Position: Q4 2025 in Review

SG Americas Securities sold out of TuHURA Biosciences (HURA) in Q4 2025, closing a stake of 16,608 shares — an estimated $41K sold.

SG Americas Securities first reported a position in HURA in Q3 2025 and held it in 1 quarter. The position peaked at $41K in Q3 2025. 65 funds tracked by Wall St. Rank hold HURA as of Q4 2025.

  • SG Americas Securities reported no remaining TuHURA Biosciences position as of Q4 2025 after selling out during the quarter.
  • SG Americas Securities sold 16,608 TuHURA Biosciences shares in Q4 2025, an estimated $41K.
  • SG Americas Securities first reported a position in TuHURA Biosciences in Q3 2025 and held it in 1 quarter.
  • SG Americas Securities's TuHURA Biosciences position peaked at $41K in Q3 2025.
  • 65 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2025.

Based on SG Americas Securities's 13F filing for Q4 2025, filed 9 Jan 2026.